Intimations To Stock Exchange | RPG Life Sciences
rpgls
  • Contact Us
  • Our Story
    • History and Milestones
    • Our Brand
    • Core Strengths
    • Vision, Values and Capabilities
    • Board of Directors
    • Management Team
    • Industry Awards and Recognition
  • Our Businesses
    • Business Portfolio
      • API
      • Domestic Formulations
      • International Formulations
      Manufacturing
      • Manufacturing Facilities
      • Quality
      • Environment, Health and Safety
      Scientific Overview
      • Research and Development
      • Patents
  • Therapeutic Focus
    • Nephrology
    • Cardiovascular
    • Anti-Diabetic
    • Orthopedic
    • Urology
    • Oncology
    • Rheumatology
    • Gastroenterology
    • Respiratory
    • Gynaecology and Pediatrics
    • Vitamins and Minerals
    • Neurology
    • Anti-Dengue
    • Dermatology
  • Life@RPGLS
    • Employee Connect
      Rewards and Recognition
      • Brave RPGLS Covid Warriors
      • Great Place To Work
      • Team Awards
      • Employee Awards
      Human Resources
      • Jobs At RPGLS
      • Company Events
      • Learning and Development
      CSR
      • Corporate Social Responsibility
      Explore Us
      Happiness Matters!!
  • Investors
    • Financial Results
      • Audited Financial Results
      • Quarterly Financial Results
      Company Presentations
      • Investor Presentations
      • Earnings Call
      • Press Release
      Mandatory Disclosures
      • Code and Policies
      Shareholders Information
      • Shareholding Pattern
      • Concepts and Procedure
      • Corporate Governance Reports
      • Annual Reports
      • Intimation to Stock Exchange
      • Notices of Board Meetings
      • Outcome of Board Meetings
      • AGM & Postal Ballot
      • Unpaid Dividend List
      • TDS on Dividend Communication
      • Forms related to Physical Shares
      • Newspaper Publications
      • Market Tracker and Credit Rating
      Investor Relations
      • Investor Education and Protection Fund
      • Investor Grievance
      • Investor Contacts
      • Investor Meets
      Committees Composition
      • Audit Committee
      • Risk Management Committee
      • Stakeholders Relationship Committee
      • Nomination & Remuneration Committee
      • SCSR Committee
      DISCLOSURES UNDER REGULATION 46 OF LODR
      • Disclosures under regulation 46 of LODR
  • Media
    • Online News and Print Media
    • RPGLS @ Industry Platforms

INTIMATIONS TO STOCK EXCHANGE
  • Home
  • intimations to stock exchange

Sr. No. File Name (Click to Download)
61 Intimation for Loss of Share Certificate October 04,2023
62 Intimation about Closing of Trading Window September 30, 2023
63 Intimation for issue of Duplicate Certificate_ September 11, 2023
64 Intimation for Loss of Share Certificate September 07,2023
65 Intimation for Loss of Share Certificate August 28,2023
66 Intimation for issue of duplicate certificate_August 25, 2023
67 Intimation for Loss of Share Certificate August 18,2023
68 Intimation for Loss of Share Certificate August 14, 2023
69 Intimation of Record Date - July 21, 2023
70 Intimation about Closing of Trading Window June 30, 2023
71 Intimation for issue of Duplicate Certificate_ June 17, 2023
72 Intimation for Loss of Certificate June 09,2023
73 Annual Secretarial Compliance Report March 31, 2023
74 Intimation for issue of Duplicate Certificate_ May 12, 2023
75 Disclosure Regulation 23(9) - Related Party for Half year ended March 31, 2023
  • Prev
  • 1
  • 2
  • ...
  • 3
  • 4
  • 5
  • 6
  • 7
  • ..
  • 11
  • 12
  • Next

Investors Information

Annual Conference Videos
  • June 16, 2021
  • Your browser does not support HTML5 video.
Company Presentations
  • Investor Presentations
  • Corporate Presentations
  • Earnings Call
  • Press Release
Financial Results
  • Audited Financial Results
  • Quarterly Financial Results
  • Dividend Declarations
Investor Relations
  • Investor Education and Protection Fund
  • Investor Grievance
  • Investor Contacts
  • Investor Meets
Share Holders Information
  • Shareholding Pattern
  • Concepts and Procedure
  • Corporate Governance Reports
  • Annual Reports
  • Intimation to Stock Exchange
  • Notices of Board Meetings
  • Outcome of Board Meetings
  • AGM & Postal Ballot
  • Unpaid Dividend List
  • TDS on dividend communication
  • Forms related to Physical Shares
  • Reg. 46 SEBI (LODR)
  • Newspaper Publications
  • Market tracker
Board Committees
  • Audit Committee
  • Risk Management Committee
  • Stakeholders Relationship Committee
  • Nomination & Remuneration Committee
  • SCSR Committee
Mandatory Disclosures
  • Code and Policies
  • Disclosures under regulation 46 of LODR
Get in Touch

QUICK LINKS

Vision

Quality

History and Milestones

Company Awards

Manufacturing Facilities

Research and Development

Offline PDF form
Drugs Safety – Adverse Event Reporting

Contact Us

  • Address:
    RPG Life Sciences Limited,
    RPG HOUSE, 463, Dr. Annie Besant Road, Worli,
    Mumbai - 400030, India

  • Phone: 91-22-69757100

  • Email:

Follow Us




Porto Website Template

RPG Life Sciences Limited © Copyright 2025-26. All Rights Reserved.

  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions
  • Sitemap